LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 3 of total 3

Search options

  1. Article ; Online: Baricitinib as rescue therapy in a patient with COVID-19 with no complete response to sarilumab.

    Cingolani, A / Tummolo, A M / Montemurro, G / Gremese, E / Larosa, L / Cipriani, M C / Pasciuto, G / Liperoti, R / Murri, R / Pirronti, T / Cauda, R / Fantoni, M

    Infection

    2020  Volume 48, Issue 5, Page(s) 767–771

    Abstract: A patient with COVID-19-related severe respiratory failure, with insufficient response ... to an antiretroviral therapy, hydroxychloroquine and Interleukin-6 (IL-6) antagonist therapy, presented a prompt ... resolution of the respiratory function and improvement in the radiological picture after baricitinib ...

    Abstract A patient with COVID-19-related severe respiratory failure, with insufficient response to an antiretroviral therapy, hydroxychloroquine and Interleukin-6 (IL-6) antagonist therapy, presented a prompt resolution of the respiratory function and improvement in the radiological picture after baricitinib at an oral dose of 4 mg per day for 2 weeks.
    MeSH term(s) Acute Disease ; Aged ; Antibodies, Monoclonal, Humanized/therapeutic use ; Antiviral Agents/therapeutic use ; Azetidines/therapeutic use ; Azithromycin/therapeutic use ; Betacoronavirus/drug effects ; Betacoronavirus/pathogenicity ; COVID-19 ; Coronavirus Infections/drug therapy ; Coronavirus Infections/physiopathology ; Coronavirus Infections/virology ; Drug Combinations ; Drug Repositioning ; Humans ; Hydroxychloroquine/therapeutic use ; Lopinavir/therapeutic use ; Male ; Pandemics ; Pneumonia, Viral/drug therapy ; Pneumonia, Viral/physiopathology ; Pneumonia, Viral/virology ; Purines ; Pyrazoles ; Respiratory Insufficiency/drug therapy ; Respiratory Insufficiency/physiopathology ; Respiratory Insufficiency/virology ; Ritonavir/therapeutic use ; SARS-CoV-2 ; Sulfonamides/therapeutic use ; Treatment Outcome
    Chemical Substances Antibodies, Monoclonal, Humanized ; Antiviral Agents ; Azetidines ; Drug Combinations ; Purines ; Pyrazoles ; Sulfonamides ; lopinavir-ritonavir drug combination ; Lopinavir (2494G1JF75) ; Hydroxychloroquine (4QWG6N8QKH) ; Azithromycin (83905-01-5) ; baricitinib (ISP4442I3Y) ; sarilumab (NU90V55F8I) ; Ritonavir (O3J8G9O825)
    Keywords covid19
    Language English
    Publishing date 2020-07-08
    Publishing country Germany
    Document type Case Reports ; Journal Article
    ZDB-ID 185104-4
    ISSN 1439-0973 ; 0300-8126 ; 0173-2129
    ISSN (online) 1439-0973
    ISSN 0300-8126 ; 0173-2129
    DOI 10.1007/s15010-020-01476-7
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Baricitinib as rescue therapy in a patient with COVID-19 with no complete response to sarilumab

    Cingolani, A. / Tummolo, A. M. / Montemurro, G. / Gremese, E. / Larosa, L. / Cipriani, M. C. / Pasciuto, G. / Liperoti, R. / Murri, R. / Pirronti, T. / Cauda, R. / Fantoni, M.

    Infection

    2020  Volume 48, Issue 5, Page(s) 767–771

    Keywords Microbiology (medical) ; Infectious Diseases ; General Medicine ; covid19
    Language English
    Publisher Springer Science and Business Media LLC
    Publishing country us
    Document type Article ; Online
    ZDB-ID 185104-4
    ISSN 1439-0973 ; 0300-8126 ; 0173-2129
    ISSN (online) 1439-0973
    ISSN 0300-8126 ; 0173-2129
    DOI 10.1007/s15010-020-01476-7
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  3. Article: Baricitinib as rescue therapy in a patient with COVID-19 with no complete response to sarilumab

    Cingolani, A / Tummolo, A M / Montemurro, G / Gremese, E / Larosa, L / Cipriani, M C / Pasciuto, G / Liperoti, R / Murri, R / Pirronti, T / Cauda, R / Fantoni, M

    Infection

    Abstract: A patient with COVID-19-related severe respiratory failure, with insufficient response ... to an antiretroviral therapy, hydroxychloroquine and Interleukin-6 (IL-6) antagonist therapy, presented a prompt ... resolution of the respiratory function and improvement in the radiological picture after baricitinib ...

    Abstract A patient with COVID-19-related severe respiratory failure, with insufficient response to an antiretroviral therapy, hydroxychloroquine and Interleukin-6 (IL-6) antagonist therapy, presented a prompt resolution of the respiratory function and improvement in the radiological picture after baricitinib at an oral dose of 4 mg per day for 2 weeks.
    Keywords covid19
    Publisher WHO
    Document type Article
    Note WHO #Covidence: #635070
    Database COVID19

    Kategorien

To top